Olink Holding Ab [Publ] ADR (NQ: OLK )
14.75 -0.06 (-0.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
All News about Olink Holding Ab [Publ] ADR
Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
September 19, 2023
Discover more with less. Unmatched specificity and sensitivity deliver translational insights from 1µl of sample.
Olink reports second quarter 2023 financial results
August 09, 2023
Olink reports first quarter 2023 financial results
May 11, 2023
Bruno Rossi joins Olink as Chief Commercial Officer
March 21, 2023
Olink reports fourth quarter and full year 2022 financial results
February 21, 2023